Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Therapeuticsmd Inc (TXMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,284,770
  • Shares Outstanding, K 231,490
  • Annual Sales, $ 16,780 K
  • Annual Income, $ -76,930 K
  • 36-Month Beta 1.53
  • Price/Sales 75.06
  • Price/Cash Flow N/A
  • Price/Book 15.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.22
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.31
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -214.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.07 +6.31%
on 08/02/18
6.85 -21.31%
on 07/20/18
-1.29 (-19.31%)
since 07/17/18
3-Month
5.07 +6.31%
on 08/02/18
7.66 -29.63%
on 06/08/18
-0.71 (-11.64%)
since 05/17/18
52-Week
4.34 +24.19%
on 11/03/17
7.66 -29.63%
on 06/08/18
-0.88 (-14.04%)
since 08/17/17

Most Recent Stories

More News
TherapeuticsMD Announces Pricing of Its Underwritten Public Offering and Concurrent Registered Direct Offering for Aggregate Gross Proceeds of $85 Million

TherapeuticsMD, Inc. (NASDAQ: TXMD) today announced the pricing of its previously announced $65 million underwritten public offering of common stock at a price to the public of $5.10 per...

TXMD : 5.39 (-2.88%)
TherapeuticsMD Licenses Population Council's Novel Segesterone Acetate/ Ethinyl Estradiol One-Year Vaginal Contraceptive System

---Significantly expands TherapeuticsMD's product portfolio and includes exclusive rights to negotiate co-development of two other investigational vaginal contraceptive systems-

TXMD : 5.39 (-2.88%)
Knight Therapeutics and TherapeuticsMD Announce Strategic Partnership

-Knight receives license to TX-004HR and TX-001HR and agrees to invest $20 million in TherapeuticsMD-

GUD.TO : 8.23 (-0.24%)
KHTRF : 6.2822 (+0.50%)
TXMD : 5.39 (-2.88%)
TherapeuticsMD Announces Proposed $65 Million Underwritten Public Offering and Concurrent $20 Million Registered Direct Offering of Common Stock

TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced the launch of a $65 million underwritten public offering and a concurrent $20 million registered direct offering to a strategic investor...

TXMD : 5.39 (-2.88%)
TherapeuticsMD Enters Oversold Territory (TXMD)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

TXMD : 5.39 (-2.88%)
TherapeuticsMD Announces Second Quarter 2018 Financial Results

---PDUFA target action date of October 28, 2018 for TX-001HR-

TXMD : 5.39 (-2.88%)
TherapeuticsMD to Report Second Quarter 2018 Financial Results on July 30, 2018

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that it will report its second quarter 2018 financial results on Monday, July 30, 2018, before...

TXMD : 5.39 (-2.88%)
Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks

Stock Research Monitor: IDXX, PTN, and ZGNX

IDXX : 243.50 (+0.10%)
PTN : 0.96 (-1.03%)
TXMD : 5.39 (-2.88%)
Therapeuticsmd Up 21.2% Since SmarTrend Uptrend Call (TXMD)

SmarTrend identified an Uptrend for Therapeuticsmd (NASDAQ:TXMD) on April 19th, 2018 at $5.85. In approximately 2 months, Therapeuticsmd has returned 21.18% as of today's recent price of $7.09.

TXMD : 5.39 (-2.88%)
TherapeuticsMD Announces Draw Down of $75 Million Under Term Loan with MidCap Financial

TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the company has completed the first draw down of $75 million under its previously announced...

TXMD : 5.39 (-2.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade TXMD with:

Business Summary

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health...

See More

Key Turning Points

2nd Resistance Point 5.61
1st Resistance Point 5.50
Last Price 5.39
1st Support Level 5.33
2nd Support Level 5.27

See More

52-Week High 7.66
Fibonacci 61.8% 6.39
Fibonacci 50% 6.00
Fibonacci 38.2% 5.61
Last Price 5.39
52-Week Low 4.34

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar